On October 29, 2024, Pfizer Inc. released its financial results for the third quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. This information, as stated in Item 2.02 of the report, is not considered 'filed' under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It also will not be incorporated by reference into any of Pfizer's filings under the Exchange Act or the Securities Act of 1933, except as explicitly referenced in such filings. The press release, which details the financial performance of Pfizer for the quarter, is available as Exhibit 99 in the report filed with the SEC.

On October 29, 2024, Pfizer Inc. released its financial results for the third quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. This information, as stated in Item 2.02 of the report, is not considered 'filed' under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It also will not be incorporated by reference into any of Pfizer's filings under the Exchange Act or the Securities Act of 1933, except as explicitly referenced in such filings. The press release, which details the financial performance of Pfizer for the quarter, is available as Exhibit 99 in the report filed with the SEC.